The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Public Service and the Rheumatologist

Public Service and the Rheumatologist

August 1, 2007 • By Bruce N. Cronstein, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Bruce N. Cronstein, MD

From jury duty to hospital committees, our institutions depend on the people of this country for community and public service. Although trying and often time consuming, this service is usually provided in good humor and with the best of intentions. Unfortunately, community service has recently earned a less lofty reputation. As punishment for miscreants, community service follows right after sincere regrets and rehabilitation for substance abuse in the “stations of the celebrity.” As documented in the news reports, for students applying for admission to top colleges, “voluntary” community service is no less a formal requirement than good grades or SAT scores.

You Might Also Like
  • Public Rarely Knows Why FDA Rejects New Drugs
  • ARHP Member Donald R. Miller, PharmD, Named to FDA Arthritis Advocacy Committee
  • ACR Releases New Position Statements on Site of Service & Compounding
Explore This Issue
August 2007
Also By This Author
  • Pharmaceutical Tourism

Certain forms of community service can be onerous but I often take pleasure in jury duty despite the time imposition. The joy is not due to just the proximity of Chinatown and its delightful restaurants to the courts in Manhattan. It is interesting to see professionals of a different sort work and take part in a process that is critical to the proper functioning of civil society. Similarly, the drudgery of committee work at my medical center has its gratifications: the satisfaction of a job well done and the sense that the commonweal has been served are their own form of recompense. Needless to say, I get a lot of this sort of satisfaction.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Letters to the the Editor: Feedback from our Readers

I enjoyed Dr. Cronstein’s recent article about pharma and CME [“Cost of a Free Lunch,” May 2007, p.4], but wondered if he or others had comments regarding the equally (or more?) disturbing issue of our own “colleagues” traveling hither and yon across the country at the behest (and reward) of pharma to educate clinicians about various therapies – including some (i.e., anti-TNF inhibitors) that have been around for a while. Don’t meetings and publications provide the same information for us? Should primary care physicians be prescribing these medications at all? Talk about influence and marketing….

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Paul H. Waytz, MD, Rheumatologist, Private Practice Arthritis and Rheumatology Consultants, Minneapolis, Minn.

To Serve or Not To Serve?

However, my ambivalence to the claims of public service was recently reinforced by an event that has left me troubled. Several months ago, I was asked to serve on the advisory committee of the Food and Drug Administration (FDA) that was tasked with reviewing the evidence for approval of a new COX2 inhibitor (Arcoxia) from Merck. When initially invited to serve on this committee, I did not think that I had any conflicts of interest. I had spoken for Merck five or six years ago and edited a Web site sponsored by Merck that went under four or five years ago. Since then, I had had little contact with the company.

Pages: 1 2 3 | Single Page

Filed Under: Legislation & Advocacy Tagged With: Advocacy, Editorials/commentary from expertsIssue: August 2007

You Might Also Like:
  • Public Rarely Knows Why FDA Rejects New Drugs
  • ARHP Member Donald R. Miller, PharmD, Named to FDA Arthritis Advocacy Committee
  • ACR Releases New Position Statements on Site of Service & Compounding
  • FDA’s ‘Breakthrough Drug’ Terminology Confuses the Public

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)